IQVIA Holdings Inc.
IQV
株式のランク
#538
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical... IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
株価
$274.69
時価総額
$45.21B
変化（1日）
2.69%
変化（1年）
25.62%
国
US
取引 IQVIA Holdings Inc. (IQV)
カテゴリー
Healthcare
IQVIA Holdings Inc.（IQV）の収益
Jun 2026 時点の収益 TTM: $16.98B
IQVIA Holdings Inc. の最新の財務報告によると、現在の収益 (TTM) は $16.98B です。2024 年には $15.41B の収益があり、これは 2023 年の $14.98B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
IQVIA Holdings Inc. の収益履歴（2010 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $16.98B | 4.13% |
| 2025 | $16.31B | 5.87% |
| 2024 | $15.41B | 2.81% |
| 2023 | $14.98B | 3.98% |
| 2022 | $14.41B | 3.86% |
| 2021 | $13.87B | 22.14% |
| 2020 | $11.36B | 2.44% |
| 2019 | $11.09B | 6.49% |
| 2018 | $10.41B | 7.32% |
| 2017 | $9.70B | 42.36% |
| 2016 | $6.82B | 18.79% |
| 2015 | $5.74B | 5.07% |
| 2014 | $5.46B | 7.07% |
| 2013 | $5.10B | 4.81% |
| 2012 | $4.87B | 12.43% |
| 2011 | $4.33B | 10.29% |
| 2010 | $3.92B | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $46.34B | 172.84% |
US
|
|
| $25.11B | 47.84% |
US
|
|
| $2.71B | -84.06% |
US
|
|
| - | - |
CN
|
|
| $7.37B | -56.59% |
US
|
